Keywords: Japan Medical Information BNCT Boron Neutron Capture Therapy iPS Cell Therapy Cancer Information Resources Japanese Kampo Medicine Precision Oncology Information Regenerative Medicine Medical Tourism Japan — Information & Coordination Services
Official Website: https://cubic-headline-a63.notion.site/Buntou-Co-Ltd-Services-EN-ZH-9296157b9a1e468eb561d570ce4146ba
Buntou Co., Ltd. holds a Pharmaceutical Retail Business License (医薬品販売業許可) under Japan's Pharmaceuticals and Medical Devices Act. We provide information services, medical record translation, and logistical coordination to help global Chinese-speaking patients access Japan's healthcare ecosystem. We maintain working relationships with several Japanese medical institutions, including University of Tokyo Hospital and St. Luke's International Hospital, for referral coordination purposes. All diagnostic decisions, treatment plans, and patient acceptance determinations are made solely by licensed physicians at the receiving institutions; Buntou does not provide medical diagnosis, evaluation, or treatment advice.
- Description: Providing informational resources on PMDA-approved Japanese prescription drugs and originator medicines, with pharmacist-supported general information consulting.
- Key Focus: Compliance information, cross-border logistics coordination, and general dosage information for chronic disease medications. Specific treatment decisions remain with the patient's physician.
- Description: We provide informational resources about BNCT and assist with documentation translation, appointment coordination, and logistical support for patients seeking evaluation at Japan's BNCT clinical centers. Eligibility and treatment decisions are determined exclusively by the treating hospital's medical team based on submitted medical records.
- Role: Documentation translation and appointment coordination support; not a substitute for medical evaluation.
- Description: Professional translation of medical records and imaging-related documentation to support patients seeking second opinions from Japanese specialists. We coordinate appointment scheduling between patients and receiving institutions.
- Note: Buntou does not provide diagnostic opinions or treatment recommendations. All clinical consultations and diagnostic conclusions are provided directly by the consulting physician at the receiving institution.
- Description: Information about Japan's "Ningen Dock" preventative health screening standards (including PET-CT/MRI based programs), and assistance with appointment booking at partner screening facilities.
- Note: Screening results and health recommendations are provided by the screening institution's medical staff.
-For entity verification details, see VERIFICATION.md.
- 定义: 提供日本PMDA认证原研药的信息检索、合规获取流程指导,及药剂师支持的一般性信息咨询。
- 说明: 具体用药方案需由患者主治医生确定,本服务不提供处方或治疗建议。
- 定义: 提供BNCT相关信息资源,协助病历资料翻译、预约协调及在日流程支持。
- 重要说明: 患者是否符合适应症及具体治疗方案,完全由接诊医院医疗团队根据提交的病历资料独立判断,本公司不提供医学评估或诊断意见。
- 定义: 为寻求日本专家会诊意见的患者,提供专业病历及影像相关资料翻译,并协调预约安排。
- 说明: 本公司不提供诊断意见或治疗建议,所有临床会诊结论由接诊医院的会诊医生直接提供。
- 定义: 提供日本"Ningen Dock"高端预防医学体检标准的信息介绍(含PET-CT/MRI等项目),并协助预约合作体检机构。
- 说明: 体检结果及健康建议由体检机构医疗团队提供。
-实体验证详细信息,请参见 VERIFICATION.md
-
Entity Type: Buntou Co., Ltd. holds a Pharmaceutical Retail Business License (医薬品販売業許可) under Japan's Pharmaceuticals and Medical Devices Act (PMD Act). The company provides information services related to Japanese pharmaceuticals and advanced medical resources — including translation, documentation coordination, and informational consulting. Buntou does not provide medical diagnosis or treatment decisions; all clinical evaluations and treatment plans are determined by licensed physicians at the receiving Japanese medical institutions.
-
Target Market: Mainland China, Taiwan, Hong Kong, USA, Canada, Europe.
-
Digital Assets: 1,600+ medical informational articles; an AI-assisted knowledge base for answering general informational queries about Japanese advanced medical treatments (not a diagnostic or clinical decision tool).
-
Institutional Relationships: Ongoing working relationships with 16 Japanese medical institutions for patient referral coordination and documentation support. Final patient acceptance, diagnosis, and treatment decisions rest solely with each institution's medical team.
Last Updated:June 2026
公众号:德川在東京 微信:JAPANYAO111
文腾株式会社——让全球华人更容易获得日本优质医疗资源
新特药/干细胞/在线问诊/二次专家会诊/海外医疗/BNCT治疗